Author: Publisher:
ISBN:
Category : Prostate
Languages : en
Pages : 8
Book Description
The Management of Clinically Localized Prostate Cancer
Author: Consensus Development Conference on the Management of Clinically Localized Prostate Cancer
Author: Management of Clinically Localized Prostate Cancer
Author: American Urological Association. Prostate Cancer Clinical Guidelines PanelPublisher:
ISBN: 9780964970205
Category : Prostate
Languages : en
Pages : 49
Book Description
Active Surveillance for Localized Prostate Cancer
Author: Laurence KlotzPublisher: Springer Science & Business Media
ISBN: 1617799122
Category : Medical
Languages : en
Pages : 212
Book Description
Active Surveillance for Localized Prostate Cancer: A New Paradigm for Clinical Management will serve as a useful resource for physicians dealing with, and interested in, this complex and evolving branch of prostate cancer management. The book will also be of interest to scientifically literate patients and their families. The volume provides an introduction to the concept of active surveillance in oncology in general and prostate cancer specifically. The primary focus is to provide a comprehensive guide to the management of patients on surveillance. The volume covers the many complexities and nuances to this approach including, patient selection, risk assessment, how to overcome 'cancer hysteria' when counseling patients, identifying appropriate triggers for intervention, use of PSA kinetics and MR imaging information, technique and frequency of biopsies, secondary prevention interventions, and the relative roles of surveillance and focal therapy.
Management of Clinically Localized Prostate Cancer
Author: National Cancer Institute (U.S.)Publisher:
ISBN:
Category :
Languages : en
Pages : 174
Book Description
Active Surveillance for Localized Prostate Cancer
Author: Laurence KlotzPublisher: Humana Press
ISBN: 3319627104
Category : Medical
Languages : en
Pages : 249
Book Description
This fully updated and revised new edition provides a comprehensive, state-of-the art review of this field, and will serve as a valuable resource for clinicians, surgeons and researchers with an interest in prostate cancer. The book reviews new data about molecular characteristics of the disease, profiles the new grading system for prostate cancer introduced in 2015, and provides new perspectives about imaging of prostate cancer, as well as the role of targeted biopsies. The text summarizes the role of biomarkers and MRI in patient selection and management and details the world wide results of active surveillance. Specific chapters address communication and ethical issues, QOL outcomes, economic aspects, and psycho-social aspects of surveillance. The role of focal therapy for low risk disease is summarized, and the data supporting preventive interventions during surveillance reviewed. This text will serve as a very useful resource for physicians and researchers dealing with, and interested in this common malignancy, as it provides a concise yet comprehensive summary of the current status of the field that will help guide patient management and stimulate investigative efforts.
National Institutes of Health Consensus Development Conference on the Management of Clinically Localized Prostate Cancer
Author: Consensus Development Conference on the Management of Clinical Localized Prostate CancerPublisher:
ISBN:
Category :
Languages : en
Pages : 185
Book Description
National Institutes of Health Consensus Development Conference on the Management of Clinically Localized Prostate Cancer
Author: Consensus Development Conference on the Management of Clinical Localized Prostate Cancer (1987, Bethesda, Md.)Publisher:
ISBN:
Category :
Languages : en
Pages : 185
Book Description
The Management of Clinically Localized Prostate Cancer
Author: National Cancer Institute. International Cancer Information CenterPublisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Management of Prostate Cancer
Author: Eric A. KleinPublisher: Springer Science & Business Media
ISBN: 1592597769
Category : Medical
Languages : en
Pages : 735
Book Description
Although much progress has been made in the four years since the first edition of Management of Prostate Cancer, prostate cancer remains a significant biological, me- cal, and personal challenge for millions of men. In this interval, some important trends and observations have emerged that represent real progress in the field and which will shape the direction of clinical practice and research in the next 5–10 years. These obs- vations include: (1) a decline in prostate-related cancer mortality in the United States, likely owing to a combination of factors including screening, more aggressive and earlier therapy, and improvements in specific therapies; (2) a significant downward pathological stage migration, so that an individual’s chance of cure for a given stage, grade, and PSA is better now than it was early in the PSA era, even without associated improvements in individual therapies; (3) the recognition of new PSA isoforms that may refine screening strategies; (4) several randomized, phase III clinical trials demonstrating survival adv- tages of one form of therapy over another in selected populations (external beam rad- therapy with adjuvant hormones vs radiotherapy alone, radical prostatectomy vs observation); (5) a focus on the biology of bone and bone metastasis, and new agents that reduce skeletal-related events and which may inhibit the growth of new metastases; (6) second-generation anti-PSMA antibodies with improved potential for imaging and therapy; (7) the development and widespread adoption of nomograms that assist in cli- cal decision-making for individual patients; (8) the identification of new genes that